logo

BLISSGVS vs WOCKPHARMA: Stock Comparison

BLISSGVS vs WOCKHARDTUpdated 2 Jul 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. BLISSGVS shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLISSGVS leads 10; WOCKPHARMA leads 1 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLISSGVSWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹6,808 Cr
₹30,126 Cr
P/E RatioBLISSGVS has the lower reading
49.75x ✓
73.66x
P/B RatioBLISSGVS has the lower reading
5.68x ✓
6.1x
EPSWOCKPHARMA has the higher reading
₹4.72
₹6.52 ✓
Book ValueContext only
₹116.14
₹325
Dividend YieldBLISSGVS has the higher reading
0.25% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,126 Cr vs ₹6,808 Cr
P/E Ratio
BLISSGVS has a lower P/E
49.75x vs 73.66x
P/B Ratio
BLISSGVS has a lower P/B
5.68x vs 6.1x
EPS
WOCKPHARMA has higher earnings per share
₹6.52 vs ₹4.72
Dividend Yield
BLISSGVS has a higher dividend yield
0.25% vs 0%
Revenue Growth (TTM YoY)
BLISSGVS has faster revenue growth
29.8% vs 26%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs 0%
ROE
BLISSGVS has a higher ROE
8.39% vs 3.77%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSWOCKPHARMA
Live Price₹527.1₹1,855.5
Day Change0.68%-1.16%
Volume3.93 L4.57 L
52-Week High₹553₹2,422.3
52-Week Low₹118₹1,086.7
Distance from 52W High-4.68%-23.4%

Valuation

MetricBLISSGVSWOCKPHARMA
Market Cap₹6,808 Cr₹30,126 Cr
P/E Ratio49.75x73.66x
P/B Ratio5.68x6.1x
EPS₹4.72₹6.52
Book Value₹116.14₹325
Dividend Yield0.25%0%

Growth

MetricBLISSGVSWOCKPHARMA
Revenue Growth (TTM YoY)29.8%26%
EPS Growth (TTM YoY)124.7%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricBLISSGVSWOCKPHARMA
ROE8.39%3.77%
ROCE9.22%5.44%
Net Margin13.93%3.3%
Operating Margin19.81%13.37%
Debt to Equity0x0.4x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLISSGVSWOCKPHARMA
Promoter Holding35.01%▼ 0.35 pp49.08%
FII Holding8.07%▼ 2.38 pp7.22%▲ 0.13 pp
DII Holding9.47%▲ 4.43 pp9.24%▼ 1.72 pp
Public Holding47.45%▼ 1.7 pp34.44%▲ 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLISSGVS and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.